Anticancer Activity of Corosolic Acid With Botanical Sources, Biopharmaceutical Profile, Mechanistic Insight, Toxicity, and Clinical Evidence
Overall, this review integrates current knowledge, identifies critical research gaps, and emphasizes the need for well-designed clinical trials to establish CRS as a viable multitarget anticancer agent.
Authors
- Atiqur Rahman (ORCID: https://orcid.org/0000-0003-4228-1149)
- Khadija Akter (ORCID: https://orcid.org/0009-0000-6373-6929)
- R Suma
- Ali G. Alkhathami (ORCID: https://orcid.org/0000-0001-5716-934X)
- Mohammed Burhan Uddin
- Emon Mia
- Md. Nasimul Haque Shipon
- Md. Sakib Al Hasan
- Abul Bashar Ripon Khalipha
Institutions
- Gopalganj Science and Technology University (BD)
- York College, City University of New York (US)
- Islamic University (BD)
- Clinical Research Organization (BD)
- Bangladesh University of Business and Technology (BD)
- King Khalid University (SA)
Publication Details
- Journal
- Phytochemical Analysis
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1002/pca.70052
- Primary Topic
- Natural product bioactivities and synthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00